Some Biochemical Changes Followed Experimental Gastric Ulceration
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 33090
Some Biochemical Changes Followed Experimental Gastric Ulceration

Authors: A. H. El-Far, R. R. Gindi, H. A. Abd El-Maksoud, Mohamed Ragaa Ragab Hassanien

Abstract:

Gastric ulceration is a discontinuity in gastric mucosa, usually occurs due to imbalance between the gastric mucosal protective factors, that is called gastric mucosal barrier, and the aggressive factors, to which the mucosa is exposed. This study was carried out on sixty male Sprague-Dowely rats (12- 16 weeks old) allocated into two groups. The first control group and the second Gastric lesion group which induced by oral administration of a single daily dose of aspirin at a dose of 300 mg/kg body weight for 7 consecutive-days (6% aspirin solution will be prepared and each rat will be given 5 ml of that solution/kg body weight). Blood is collected 1, 2 and 3 weeks after induction of gastric ulceration. Significant increase in serum copper, nitric oxide, and prostaglandin E2 all over the period of experiment. Significant decrease in erythrocyte superoxide dismutase (t-SOD) activities, serum (calcium, phosphorus, glucose and insulin) levels. Non-significant changes in serum sodium and potassium levels are obtained.

Keywords: Aspirin, Gastric Ulcer, Prostaglandin E2, Superoxide dismutase

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1083809

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1612

References:


[1] N. D. Yeomans and J. Naesdal "Systematic review: ulcer definition in NSAID ulcer prevention trials". Aliment Pharmacol Ther, 27(6):465-472. 2008.
[2] M. Bhattacharjee, S. Bhattacharjee, A. Gupta and R. K. Banerjee, "Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and non-mediated gastric ulcer". Free Radical Biol Med.;3:731-743. 2002.
[3] D. Bandyopadhyay, K. Biswas, M. Bhattacharyya, R. J. Reiter and R. K. Banerjee, "Gastric toxicity and mucosal ulceration induced by oxygenderived reactive species, protection by melatonin". Curr Mol Med.;1:501-513. 2001.
[4] J. Higham, J. Kang and A. Majeed, "Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of hemorrhage among older subjects". Gut;50(4):460-464. 2002.
[5] M. Blaser, "An endangered species in the stomach". Scientific America, 92(2): 38-45. 2005.
[6] G. Wu, and S. M. Morris, "Arginine metabolism: nitric oxide and beyond". Biochem J., 3336(1): 1-17. 1998.
[7] M. Beers, and R. Berkow, "The merck manual for diagnosis and therapy". 17th ed. US:A, Whitehouse station: Merck Research Laboratories; 18: 19-23. 2006.
[8] M. Jainu, V. Mohan and S. Devi, "Protective effect of Cissus quadrangular is on neutrophil mediated tissue injury induced by aspirinin rats". Journal of Ethnopharmacology, vol. 104, no. 3, pp. 302-305. 2006.
[9] M. Fesharaki, A. Nasiml, S. Mokhtari, R. Mokhtari, R. Moradian and N. Amirpoor, "Reactive oxygen metabolites and anti-oxidative defenses in aspirin- induced gastric damage in rats: Gastroprotectin by Vitamin E". Patholphysiology, 13(4): 237-243. 2006.
[10] A. Kornburg, and D. Korecker, "Methods of Enzymology" Acad. Press. New York. pp. 323. 1955.
[11] P. N. Bories, and C. Bories, "Nitrate determinations in biological fluids by an enzymatic one step assay with nitrate reductase". Clin. Chem. 41: 941-909. 1995.
[12] M. Wilson, and L. Miles, "Hand book of Radioimmunoassay" 1st Ed. G.E. Abraham Ed. New York. pp. 88-115. 1977.
[13] N. N. Tietz,"Fundamental of clinical chemistry". 3rd Ed. Philadelphia pp. 876. 1976.
[14] P. Trinder, "Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor". Ann. Clin. Biochem., 6, 24-25. 1969.
[15] R. F. Henry,"Clinical chemistry principles and technics". 2nd ed. Harper and Row, Hagerstein, M.D. pp. 339. 1974.
[16] J. Willis, "The determination of metals in blood serum by atomic absorption spectrophotometery". Sept. Chem. Acta (16): 259-265. 1960.
[17] R. Steel, J. Torrie, and D. Dickey, "Principles and Procedures of Statistics": A Biometrical Approach, 3rd ed., McGraw-Hill, New York, NY. 1997.
[18] M. Ham and J. Kaunitz, "Gastroduodenal defense". Curr Opin gastroenterol, 23(6):607- 616. 2007.
[19] C. T. Dillon, T. W.; Hambley, B. j. Kennedy, P. A. Lay, J. E. Weder and Q. Zhou, "Copper and zinc complexes as anti-inflammatory drugs". Met Ion Biol. Syst., 41: 253-277. 2004.
[20] E. Pontiki, D. Hadjipavlou-Litina, A. T. Chaviara and C. A. Bolos “Evaluation of anti-inflammatory and antioxidant activities of mixedligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline”. Bioorganic & Medicinal Chemistry Letters, 16(8): 2234-2237. 2006.
[21] P. C. Konturek, S. J. Konturek, and W. Ochmanski, “Neuroendocrinology of gastric H+ and Duodenal HCO3 - secretion: the role of brain-gut axis”. Eur J Pharmacol; 499(1-2):15-27. 2004.
[22] B. Zhou, J. Li, G. Cai, J. Ling and X. Dai, “Therapeutic effects of the combination of traditional Chinese medicine and western medicine on patients with peptic ulcers”. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 30(6):714-718. 2005.
[23] J .L. Wallace, and L. Ma, “Inflammatory mediators in gastrointestinal defense and injury”. Exp. Biol. Med. (Maywood) 26(11): 3-15. 2001.
[24] G. Dengiz, F. Odabasoglu, Z. Halici, E. Cadirci and H. Suleyman, “Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats”. J Phannacol Sci;105(1 ): 94-102. 2007.
[25] S. Kwiecien, M .W. Pawlik, T. Brzozowski, P. C. Konturek, Z. Sliwowski, W. W. Pawlik, and S. J. Konturek, “Nitric oxide (NO)- releasing aspirin and (NO) donors in protection of gastric mucosa against stress”. J Physiol Pharmacol; 59 Suppl 2: 103-115. 2008.
[26] T. Kunikata, H. Araki, M. Takeeda, S. Kato and K. Takeuchi, “Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes”. J Physiol Paris; 95(1- 6):157-163. 2001.
[27] K. Suzuki, H. Araki, H. Mizoguchi and K. Takeuchi, “E-type prostaglandin inhibit indomethacin induced gastric lesions in rats through EP1 receptors. Importance of antigastric motility action”. Digestion; 63: 92-101. 2001.
[28] T. Ohno, M. Katori, M. Majima, T. Saeki, K. Boku, K. Nishiyama, H. Hayashi, and K. Saigenji, “Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors”. Aliment Pharmacol Ther; 13: 1243-1250. 1999.
[29] A. E. Halley and K. H. Cheeseman, “Measuring free radical reactions in vivo”. British Medical Bulletin, 49: 494-505. 1993.
[30] T. J. Guzik, R. Korbut and T. Adamek-Guzik, “Nitric oxide and superoxide dismutase in inflammation and immune regulation”. J. Of Physiology and Pharmacol., 54(4): 469-487. 2003.
[31] J. Petersson, M. I. Phillipson, E. A. Jansson, A. Patzak, J. O. Lundberg and L. Holm, “Dietary nitrate increases gastric mucosal blood flow: and mucosal defense”. Am J. Physiol. Gastrointest Liver Physiol., 292(3): G718-724. 2007.
[32] A. Yanaka, “Role of heat shock protein in gastric mucosal protection”. Nippon Rinsho, 65(10): 1890-1895. 2007.
[33] M. Chattopadhyay, A. V. Carlos, P. April, V. N. Kamran, R. A. Khaled, K. K. Larry and K. Khosrow, “Comparison between 3-Nitrooxyphenyl acetylsalicylate (NOASA) and O2 -(acetylsalicyloxymethyl)-1- (pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as Safe Anti- Inflammatory, Analgesic, Antipyretic, Antioxidant Prodrugs”. The Journal of Pharmacology and Experimental Therapeutics, 335:443–450. 2010.
[34] A. Senol, M. Isler, A. G. Karahan, G. B. Kilic, H. Kuleasan, I Goren, U. Sarits, S. Kaya, M. Ciris, O. Akutrk, B. C. Aridogan, L. Demirin and M. Cakmakci, “Effect of probiotics on aspirin-induced gastric mucosal lesions”. Turk J Gastroenterol; 22 (1): 18-26. 2011.
[35] S. Hellgren, G. Flemstrom and O. Nylander, “Nitric oxide prevents rat duodenal contractions induced by potentially noxious agents”. Acta Physiol Scand; 169: 237-247. 2000.
[36] R. H. Boger, S. M. Bode- Boger, W. Thiele, W. Junker, K. Alexander and J. C. Frolich, “Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease”. Circulation, 95(8): 2068-2074. 1997.
[37] S. Bahadir, H. Zekai, O. Fehmi and G. Fatma, “The Effect of Lacidipine on Indomethacin Induced Ulcers in Rats”. International Journal of Pharmacology, 8: 115-121. 2012.